NEW YORK (
CHANGE IN RATINGS
was upgraded at Nomura to buy. Stock is trading at just 0.27 times expected 2015 sales, and the current cycle appears sustainable.
was upgraded at BMO Capital Markets to market perform, despite decreased earnings projections and $73 price target. Concerns about price volatility led to a selloff that improved CMP valuation to its peers, BMO Capital Markets said.
Compass Minerals was downgraded to hold at TheStreet Ratings.
was upgraded at Barrington Research to outperform from market perform. Price target is $110. Recent selloff was an overreaction, as the company still has sustained growth potential, Barrington Research said.
was downgraded at MKM Partners to sell. $33 price target. Channel checks suggest that near-term sales could fall short of expectations, MKM Partners said.
was upgraded at Lazard Capital Markets to buy from neutral. The second quarter of 2013 marks the low point of earnings cycle, and major earnings and margin improvement are seen for the second half of 2013, Lazard Capital Markets said.
was downgraded to sell at TheStreet Ratings.
was downgraded at Morgan Stanley to equal-weight from overweight. Shares have outperformed OSX by 50%, downgrading on valuation, Morgan Stanley said. Price target increased to $120.
(JEC - Get Report)
was downgraded at FBR to market perform from outperform. Valuation call, based on a $63 price target, FBR said.
(JIVE - Get Report)
was downgraded at Robert Baird to neutral from outperform. A large number of deals appear to have slipped through the cracks this quarter, Baird said.
was downgraded at BMO Capital Markets to market perform. Concerns about agricultural commodity prices arose, said BMO Capital Markets. Price volatility negatively impacts MOS' price advantages and bottom line, BMO Capital said.
Mosaic was downgraded at Morgan Stanley to equal-weight. Substantial change to the potash market is an unequivocal negative, Morgan Stanley said.
was downgraded at Wells Fargo to market perform from outperform. Valuation range is $14-$17. Tegra sales are uncertain, and there are concerns of losing GPU market share, Wells Fargo said.
Owens & Minor
was upgraded at Robert Baird to neutral from underperform. $35 price target. Market is challenged, but the company's future appears brighter, Robert Baird said.